Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allergan's president Michael Ball to join Hospira; chairman & CEO David Pyott to resume president role

This article was originally published in Scrip

Executive Summary

Allergan has reappointed David Pyott as president, effective 27 March. He will continue to serve as chairman and chief executive officer, and will fill the role of the company's current president, Michael Ball, who has been named CEO of the speciality pharmaceutical and medication delivery company Hospira. Upon his appointment on 28 March, Mr Ball will succeed Hospira's founding CEO, Christopher Begley, who will then assume the role of executive chairman.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC012157

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel